Tonix Pharmaceuticals To Start Mid-Stage Long COVID Trial In Q4
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) received the official minutes from a Type B pre-Investigational New Drug Application (IND) meeting with the…
The Daily Biotech Pulse: Cara’s Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 23)
Tonix Pharmaceuticals Announces Results Of Pre-IND Meeting With FDA For TNX-102 SL As A Potential Treatment for Long COVID Syndrome; Based On Minutes, Co. Plans To Submit IND In Q4 OD 2021
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it received the official minutes from a Type B pre-Investigational New Drug
TNXP: Multiple COVID Programs and Building Domestic Vaccine Research Infrastructure…
By David Bautz, PhD
NASDAQ:TNXP
READ THE FULL TNXP RESEARCH REPORT
Tonix Pharmaceuticals Q2 EPS $(0.07) Up From $(0.23) YoY
Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(0.07) per share. This is a 69.57 percent increase over losses of $(0.23) per share from the same period last year.
Mid-Afternoon Market Update: Dow Rises 50 Points; Iterum Therapeutics Shares Slide
Toward the end of trading Monday, the Dow traded up 0.15% to 35,112.39 while the NASDAQ fell 0.10% to 14,822.88. The S&P also rose, gaining 0.09% to 4,415.85.
48 Stocks Moving In Monday’s Mid-Day Session
Gainers
Bit Digital, Inc. (NASDAQ: BTBT) gained 38% to $5.83 after the company announced it entered into a second strategic co-mining agreement with Digihost Technology Inc. The stock is also trading higher in sympathy with the price of Bitcoin.
40 Stocks Moving in Monday’s Pre-Market Session
Gainers
Dynatronics Corporation (NASDAQ: DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on Friday.